Rupam Manna/LinkedIn
May 9, 2026, 22:18
Rupam Manna: Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery
Rupam Manna, Postdoctoral Student – DrNB Medical Oncology at National Board of Examinations, shared a post on LinkedIn:
”Thrombocytopenia in Oncology – Complete High-Yield Guide for Safe Chemotherapy Delivery!
From definition and grading to all causes (CIT, marrow infiltration, radiation, immune-mediated, hypersplenism, DIC) – clinical manifestations – evaluation – platelet thresholds for chemo and procedures – impact on treatment outcomes.
Key sections:
- Common culprit drugs (carboplatin, gemcitabine, temozolomide, PARP inhibitors, checkpoint inhibitors & more)
- Practical platelet thresholds for chemo, central lines, LP, surgery
- Treatment ladder: Transfusions, chemo modification, TPO-RAs (romiplostim, eltrombopag, avatrombopag)
- Prophylaxis and important oncology pearls (carboplatin nadir, persistent thrombocytopenia clues)
Reduces delays, dose reductions and improves quality of life plus survival!”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering